These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Expression of insulin receptor substrate 1 in primary breast cancer and lymph node metastases. Koda M; Sulkowska M; Kanczuga-Koda L; Sulkowski S J Clin Pathol; 2005 Jun; 58(6):645-9. PubMed ID: 15917419 [TBL] [Abstract][Full Text] [Related]
3. Down-regulation of insulin-like growth factor-I receptor and insulin receptor substrate-1 expression in advanced human breast cancer. Schnarr B; Strunz K; Ohsam J; Benner A; Wacker J; Mayer D Int J Cancer; 2000 Nov; 89(6):506-13. PubMed ID: 11102895 [TBL] [Abstract][Full Text] [Related]
4. [Expression and intranuclear distribution of nucleolin in estrogen receptor-negative and estrogen receptor-positive breast cancers in women measured by laser scanning cytometry]. Masiuk M Ann Acad Med Stetin; 2006; 52(2):23-32. PubMed ID: 17633394 [TBL] [Abstract][Full Text] [Related]
5. Differential expression of estrogen receptor α, β1, and β2 in lobular and ductal breast cancer. Huang B; Omoto Y; Iwase H; Yamashita H; Toyama T; Coombes RC; Filipovic A; Warner M; Gustafsson JÅ Proc Natl Acad Sci U S A; 2014 Feb; 111(5):1933-8. PubMed ID: 24449868 [TBL] [Abstract][Full Text] [Related]
6. Dissociated overexpression of cathepsin D and estrogen receptor alpha in preinvasive mammary tumors. Roger P; Daures JP; Maudelonde T; Pignodel C; Gleizes M; Chapelle J; Marty-Double C; Baldet P; Mares P; Laffargue F; Rochefort H Hum Pathol; 2000 May; 31(5):593-600. PubMed ID: 10836299 [TBL] [Abstract][Full Text] [Related]
7. Expression of estrogen receptor alpha and progesterone receptor in normal human breast epithelium. Umekita Y; Souda M; Ohi Y; Rai Y; Sagara Y; Sagara Y; Yoshida H In Vivo; 2007; 21(3):535-9. PubMed ID: 17591366 [TBL] [Abstract][Full Text] [Related]
8. Expression of periostin in human breast cancer. Puglisi F; Puppin C; Pegolo E; Andreetta C; Pascoletti G; D'Aurizio F; Pandolfi M; Fasola G; Piga A; Damante G; Di Loreto C J Clin Pathol; 2008 Apr; 61(4):494-8. PubMed ID: 17938160 [TBL] [Abstract][Full Text] [Related]
9. The localization of the insulin-like growth factor receptor 1 (IGFR-1) in benign and malignant breast tissue. Happerfield LC; Miles DW; Barnes DM; Thomsen LL; Smith P; Hanby A J Pathol; 1997 Dec; 183(4):412-7. PubMed ID: 9496257 [TBL] [Abstract][Full Text] [Related]
10. Overexpression of WWP1 is associated with the estrogen receptor and insulin-like growth factor receptor 1 in breast carcinoma. Chen C; Zhou Z; Sheehan CE; Slodkowska E; Sheehan CB; Boguniewicz A; Ross JS Int J Cancer; 2009 Jun; 124(12):2829-36. PubMed ID: 19267401 [TBL] [Abstract][Full Text] [Related]
11. [Cytoplasmic expression of aquaporin-1 in breast cancer cells and its relationship with clinicopathological characteristics and prognosis]. Zhang B; Liu FF; Ma YJ; Gu F Zhonghua Zhong Liu Za Zhi; 2013 Dec; 35(12):904-9. PubMed ID: 24506959 [TBL] [Abstract][Full Text] [Related]
12. Preserved Axin expression is associated with an aggressive phenotype in invasive breast carcinomas. Irini T; Paraskevi A; Ioanna G; Christos P; Lydia N APMIS; 2013 Sep; 121(9):797-805. PubMed ID: 23278310 [TBL] [Abstract][Full Text] [Related]
13. Leupaxin is expressed in mammary carcinoma and acts as a transcriptional activator of the estrogen receptor α. Kaulfuss S; Herr AM; Büchner A; Hemmerlein B; Günthert AR; Burfeind P Int J Oncol; 2015 Jul; 47(1):106-14. PubMed ID: 25955236 [TBL] [Abstract][Full Text] [Related]
14. Investigation of immunohistochemical ERα, ERβ and ERβcx expressions in normal and neoplastic breast tissues. Bozkurt KK; Kapucuoğlu N Pathol Res Pract; 2012 Mar; 208(3):133-9. PubMed ID: 22336175 [TBL] [Abstract][Full Text] [Related]
15. Expression of osteoprotegerin (OPG), TNF related apoptosis inducing ligand (TRAIL), and receptor activator of nuclear factor kappaB ligand (RANKL) in human breast tumours. Van Poznak C; Cross SS; Saggese M; Hudis C; Panageas KS; Norton L; Coleman RE; Holen I J Clin Pathol; 2006 Jan; 59(1):56-63. PubMed ID: 16394281 [TBL] [Abstract][Full Text] [Related]
16. Changes in subcellular localisation of MI-ER1 alpha, a novel oestrogen receptor-alpha interacting protein, is associated with breast cancer progression. McCarthy PL; Mercer FC; Savicky MW; Carter BA; Paterno GD; Gillespie LL Br J Cancer; 2008 Aug; 99(4):639-46. PubMed ID: 18665173 [TBL] [Abstract][Full Text] [Related]
17. Id4 messenger RNA and estrogen receptor expression: inverse correlation in human normal breast epithelium and carcinoma. de Candia P; Akram M; Benezra R; Brogi E Hum Pathol; 2006 Aug; 37(8):1032-41. PubMed ID: 16867866 [TBL] [Abstract][Full Text] [Related]
18. Expression of ERalpha and ERbeta in lobular carcinoma in situ. Middleton LP; Perkins GH; Tucker SL; Sahin AA; Singletary SE Histopathology; 2007 Jun; 50(7):875-80. PubMed ID: 17543077 [TBL] [Abstract][Full Text] [Related]
19. Prognostic value of phosphorylated HER2 in HER2-positive breast cancer patients treated with adjuvant trastuzumab. Kurebayashi J; Kanomata N; Yamashita T; Shimo T; Mizutoh A; Moriya T; Sonoo H Breast Cancer; 2015 May; 22(3):292-9. PubMed ID: 23749689 [TBL] [Abstract][Full Text] [Related]
20. The pattern of expression of the microtubule-binding protein RHAMM/IHABP in mammary carcinoma suggests a role in the invasive behaviour of tumour cells. Assmann V; Gillett CE; Poulsom R; Ryder K; Hart IR; Hanby AM J Pathol; 2001 Sep; 195(2):191-6. PubMed ID: 11592098 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]